Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 25 citing articles:

Oxadiazole: A highly versatile scaffold in drug discovery
Nisheeth C. Desai, Jahnvi D. Monapara, Aratiba M. Jethawa, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 9
Closed Access | Times Cited: 35
Targeting the RAS upstream and downstream signaling pathway for Cancer treatment
Md. Arafat Hossain
European Journal of Pharmacology (2024) Vol. 979, pp. 176727-176727
Closed Access | Times Cited: 7
Discovery of 2,4-diaminopyrimidine derivatives as potent inhibitors of FAK capable of activating the Hippo pathway for the treatment of esophageal squamous cell carcinoma
Xiao Wang, Yin-Ru Li, Ji Wu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117328-117328
Closed Access
Sulforaphane Potentiates Gemcitabine-Mediated Anti-Cancer Effects against Intrahepatic Cholangiocarcinoma by Inhibiting HDAC Activity
Fumimasa Tomooka, Kosuke Kaji, Norihisa Nishimura, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 687-687
Open Access | Times Cited: 15
Exploring the Therapeutic Potential of Focal Adhesion Kinase Inhibition in Overcoming Chemoresistance in Pancreatic Ductal Adenocarcinoma
Fabio Scianò, Francesca Terrana, Camilla Pecoraro, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 3, pp. 271-289
Closed Access | Times Cited: 4
Novel acrylonitrile derived imidazo[4,5-b]pyridines as antioxidants and potent antiproliferative agents for pancreatic adenocarcinoma
Ida Boček, Leentje Persoons, Dirk Daelemans, et al.
International Journal of Biological Macromolecules (2024) Vol. 266, pp. 131239-131239
Closed Access | Times Cited: 3
Synthetic and anti-cancer activity aspects of 1, 3, 4-thiadiazole containing bioactive molecules: A concise review
Vincent A. Obakachi, Babita Kushwaha, Narva Deshwar Kushwaha, et al.
Journal of Sulfur Chemistry (2021) Vol. 42, Iss. 6, pp. 670-691
Closed Access | Times Cited: 17
Design, synthesis, and antibacterial activity of a new series of ciprofloxacin-thiadiazole hybrid
Eman O. Osman, Heba Attia, Reham Samir, et al.
Journal of Molecular Structure (2023) Vol. 1282, pp. 135135-135135
Closed Access | Times Cited: 5
Biological activity and computational analysis of novel acrylonitrile derived benzazoles as potent antiproliferative agents for pancreatic adenocarcinoma with antioxidative properties
Anja Beč, Leentje Persoons, Dirk Daelemans, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107326-107326
Closed Access | Times Cited: 1
Rutaecarpine-inspired scaffold-hopping strategy and Ullmann cross-coupling based synthetic approach: Identification of pyridopyrimidinone-indole based novel anticancer chemotypes
Mukul Yadav, Nibedita Roy, Kartik Mandal, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 109, pp. 117799-117799
Closed Access | Times Cited: 1
Benzothiazole a privileged scaffold for Cutting-Edges anticancer agents: Exploring drug design, structure-activity relationship, and docking studies
I. Aayishamma, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116831-116831
Closed Access | Times Cited: 1
Divergent Strategy for the Synthesis of Indolopyrazines Fused to Benzopyrimidinones and Benzimidazoles: Identification of Antiproliferative Molecules
Bilal O. Alkubaisi, Anusha Sebastian, Maximilian Bauer, et al.
ChemistrySelect (2023) Vol. 8, Iss. 46
Closed Access | Times Cited: 4
Therapeutic Charisma of Imidazo [2,1-b] [1,3,4]-Thiadiazole Analogues: A Patent Review
Anuradha Mehra, Rekha Sangwan, Aryan Mehra, et al.
Pharmaceutical Patent Analyst (2023) Vol. 12, Iss. 4, pp. 177-191
Closed Access | Times Cited: 2
Novel 1,3-Indanedione-Thiazole Hybrids as Small-Molecule SARS-COV-2 Main Protease Inhibitors With Potential anti-Coronaviral Activity
Thoraya A. Farghaly, Ghada S. Masaret, Hanan Gaber Abdulwahab
Polycyclic aromatic compounds (2024), pp. 1-16
Closed Access
The G-Protein-Coupled Estrogen Receptor Selective Agonist G-1 Attenuates Cell Viability and Migration in High-Grade Serous Ovarian Cancer Cell Lines
Donia Hanafi, Rob U. Onyenwoke, K. Sean Kimbro
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6499-6499
Open Access
The therapeutic potential and application of marine alkaloids in treating breast cancer
Jing Yu, Xinmin Wang, Peixin Du, et al.
Frontiers in Marine Science (2024) Vol. 11
Open Access
Development of Novel Focal Adhesion Kinase (FAK) Inhibitors for Targeting Cancer: Structural Insights and Therapeutic Potential
Yingnan Li, Yuming Zhang, Jifa Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116913-116913
Closed Access
Biomarkers to predict the benefits of immune‑checkpoint blockade‑based therapy in patients with malignant peritoneal mesothelioma (Review)
Chunhong Wang, Yan Zhao, Wanru Liang
Oncology Letters (2024) Vol. 28, Iss. 6
Open Access
The BET inhibitor sensitivity is associated with the expression level of CDC25B in pancreatic cancer models
Aubrey L. Miller, Patrick L. Garcia, Rebecca B. Vance, et al.
Cancer Drug Resistance (2024)
Open Access
Construction and Validation of a Novel T/NK-Cell Prognostic Signature for Pancreatic Cancer Based on Single-Cell RNA Sequencing
Yu Wang, Cong Zhang, Jianlu Zhang, et al.
Cancer Investigation (2024) Vol. 42, Iss. 10, pp. 876-892
Open Access
Discovery of A Potent Anticancer Agent against Pancreatic Ductal Adenocarcinoma Targeting FAK with DFG-out State and JAK/Aurora Kinases
Rong‐Hong Zhang, Ting Chen, Qianqian Xiong, et al.
European Journal of Medicinal Chemistry (2024) Vol. 282, pp. 117059-117059
Closed Access
Anticancer Effect of Novel Phthalazines Derivatives: Synthesis, Biological Evaluation, DFT, ADMET and Docking Study
Walid Ettahiri, Driss Fadili, Mohammed M. Alanazi, et al.
Journal of Molecular Structure (2024), pp. 141173-141173
Closed Access
In vitro and in silico insights into antimicrobial and anticancer activities of novel imidazo[2,1-b][1,3,4]thiadiazoles
Deepika Dwarakanath, Yogeesha N. Nayak, K. Ananda, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Design, synthesis, and structure–activity relationships of five-membered heterocyclic incorporated aryl(alkyl)azoles: From antiproliferative thiazoles to safer anticonvulsant oxadiazoles
Mehdi Valipour, Majid Ghasemian, Saeed Karima, et al.
Bioorganic Chemistry (2024) Vol. 155, pp. 108117-108117
Closed Access
SF3B1 modulators affect key genes in metastasis and drug influx: a new approach to fight pancreatic cancer chemoresistance
Ornella Randazzo, Stella Cascioferro, Camilla Pecoraro, et al.
Cancer Drug Resistance (2021)
Open Access | Times Cited: 4
Page 1

Scroll to top